Pacira BioSciences, Inc. (NASDAQ:PCRX – Get Rating) has earned a consensus rating of “Moderate Buy” from the thirteen analysts that are covering the company, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The average 12 month price target […]
Hussman Strategic Advisors Inc. bought a new position in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX – Get Rating) during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor bought 46,800 shares of the company’s stock, valued at approximately $1,807,000. Hussman Strategic Advisors Inc. owned […]
Pacira BioSciences (NASDAQ:PCRX – Get Rating) had its target price reduced by Piper Sandler from $63.00 to $62.00 in a research report sent to investors on Tuesday morning, The Fly reports. Other equities research analysts have also issued reports about the company. StockNews.com started coverage on Pacira BioSciences in a research report on Thursday, March […]
Pacira BioSciences (NASDAQ:PCRX – Get Rating)‘s stock had its “buy” rating reissued by Needham & Company LLC in a report issued on Thursday, Benzinga reports. They currently have a $60.00 price target on the stock. Needham & Company LLC’s price target would suggest a potential upside of 29.00% from the company’s previous close. PCRX has […]
Pacira BioSciences, Inc. (NASDAQ:PCRX – Get Rating) has been given a consensus rating of “Moderate Buy” by the thirteen ratings firms that are presently covering the firm, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The average twelve-month target […]